For its third fiscal quarter (ending September 30), Boston Scientific Corp (NYSE: BSX) has reported E.P.S. of $0.32 compared to $0.34 a year ago. For the latest four quarters through September 30, E.P.S. were $1.22 compared to $0.83 a year ago.
Recent Price Action
Boston Scientific Corp (NYSE: BSX) stock closed at $87.45 on 10/23/24 after a slight decline of -0.6%. Moreover, trading volume in this decline was exceptionally high at 370% of normal. The stock has risen 0.8% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
BSX’s future returns on capital are forecasted to exceed the cost of capital. Accordingly, the company is expected to continue to be a major Value Builder.
Boston Scientific has a current Value Trend Rating of C (Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Boston Scientific has a poor Appreciation Score of 18 but a good Power Rating of 80, leading to the Neutral Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment